Trials / Sponsors / Recognify Life Sciences
Recognify Life Sciences
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) Cognitive Impairment Associated With Schizophrenia (CIAS), Cognitive Impairment, Schizophrenia | Phase 2 | 2022-12-08 |
| Completed | Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia Cognitive Impairment, Schizophrenia | Phase 2 | 2021-04-26 |